Publications

Search for Publications

List of Publications

Sort by: Date | Author | Title

Dalgaard, I. K., Rask, C. U., Bilenberg, N. & Hulgaard, D. R. (2024). Pandemic life in families with health anxiety symptoms, parental perspectives. Scandinavian Journal of Child and Adolescent Psychiatry and Psychology, 12(1), 23-32. https://doi.org/10.2478/sjcapp-2024-0003
Silverberg, J. I., Wollenberg, A., Stein Gold, L., Yosipovitch, G., Lio, P., Vestergaard, C., Ständer, S., Carrascosa, J. M., Gallo, G., Casillas, M., Ding, Y., Yang, F. E., Pierce, E., Agell, H. & Del Rosso, J. (2025). Lebrikizumab provides stable skin response with no or minimal fluctuations for up to 2 years in patients with atopic dermatitis. Clinical and Experimental Dermatology. Advance online publication. https://doi.org/10.1093/ced/llaf490
Dulai, A. S., Murase, E. M., Avallone, G., Ferrucci, S. M., Marzano, A. V., Ribero, S., Ardern-Jones, M., Ko, E., Flohr, C., Leshem, Y. A., Deleuran, M., Vestergaard, C., Hijnen, D., Md, J. B., Elman, S. A., Pruneddu, S., Butler, D., Chovatiya, R., Girolomoni, G. ... Murase, J. E. (2026). International Multi-Center Case Series of Gestational Dupilumab Exposure in the Treatment of Atopic Dermatitis: Maternal Complications and Fetal Outcomes. Journal of the American Academy of Dermatology, 94(3), 936-940. https://doi.org/10.1016/j.jaad.2025.10.123
Zhang, D. G., Nielsen, M.-L., Sørensen, J. A., Naassan, S., Pedersen, N. H., Østergaard, C. E. S., Vestergaard, C., Ali, Z., Thyssen, J. P., Egeberg, A. & Thomsen, S. F. (2025). Early response patterns on omalizumab predict long-term outcomes in chronic spontaneous urticaria. Journal of the European Academy of Dermatology and Venereology : JEADV. Advance online publication. https://doi.org/10.1111/jdv.70158